Country / Subjects | Sensitivity to | References |
Australia, Victoria
97 cow's milk allergic children |
soy milk 47% (questionaire) | Bishop et al. 1990 |
Crotia, Zagreb
35 animal feed workers |
soybean 29% (SPT) | Zuskin et al. 1992 |
France, Meuse
742 agricultural workers |
soybean dust 6.5% (SPT) | Maria et al. 1991 |
France, Pierre Benite
580 patients with adverse reactions to food |
soybean 30% | Andre et al. 1994 |
Germany,Berlin
107 children with atopic dermatitis |
soybean 16% (n=45, DBPCFC) | Niggemann et al. 1999 |
Germany,Bonn
250 patients with suspected food allergy |
soybean 10% | Mistereck et al. 1992 |
Germany, Ulm
24 legume-sensitive adults |
soybean 21% (SPT, RAST) | Hagner et al. 1998 |
Italy, Milano
71 children with food intolerance |
soybean 17% | Bardare et al. 1988 |
Italy, Milano
704 atopic children |
soybean 21% (SPT),
from which 6% were DBPCFC-positive |
Magnolfi et al. 1996 |
Italy, Rome
371 children with food allergy |
soy 22% (RAST)
soy 3% (positive challenge) |
Giampietro et al. 1992 |
Italy, Rome
174 infants at risk for atopy |
soybean 5% (RAST) | Bruno et al. 1995 |
Italy, Rome
a) 505 children with food allergy b) 243 children at risk for atopy |
a) soybean 6% (SPT) from which 19% had positive challenge
b) soybean 6% (SPT) from which 1/14 were DBPCFC-positive |
Bruno et al. 1997 |
Japan, Tokyo
39 children with positive food challenge |
soybean 10% | Iwasaki et al. 1994 |
Japan, Tokushima
patients with atopic dermatitis |
soybean 20% (SDS-PAGE immunoblot) | Ogawa et al. 1991 |
Netherlands, Rotterdam
91 patients with atopic dermatitis |
soybean 1% (SAFT) | Oranje et al. 1992 |
Spain, Cartagena
patients with asthma (associated to asthma outbreak during the unloading of soybeans) |
soybean 81% (SPT) | Navarro et al. 1993 |
Spain, Tarragona
15 atopic patients affected by a soybean asthma outbreak |
soybean 87% (SPT) | Garcia-Ortega et al. 1998 |
South Afrika, Johannesburg
22 workers exposed to soybean dust |
soybean 36% (SPT)
soybean 36% (RAST) |
Roodt & Rees 1995 |
Sweden, Linköping
76 healthy newborn babies (at 8 months) |
soybean 6% (RAST)
(0% at 3, 25, and 48 months) |
Hattevig et al. 1984 |
Sweden, Malmö
20 cow's milk allergic infants |
soybean in 35% | Jakobsson &Lindberg 1979 |
Sweden
60 severe allergic reactions caused by food |
soybean, nuts and almonds >70% | Foucard et al. 1997 |
Switzerland, Zurich
402 food allergic adults |
soybean 1% | Wüthrich 1993 |
Thailand, Bangkok
cow's milk-sensitive children |
soybean 17% | Harikul et al. 1995 |
Thailand
100 asthmatic children |
soy 4% | Kongpanichkul et al. 1997 |
USA, Baltimore, MD
196 food-allergic patients with atopic dermatitis |
soybean 28% (DBPCFC, n=111) | Sampson & Ho 1997 |
USA, Denver, CO
180 food allergic children |
soy 6% (DBPCFC) | Bock & Atkins 1990 |
USA, Little Rock, AR
165 patients with atopic dermatitis |
soybean 13% (SPT) from which 3/19 were DBPCFC-positive | Burks et al. 1998 |
USA, New Haven, CT
98 infants and children with multiple gastrointestinal allergies |
soy and milk 62%
soy and gluten 35% |
Gryboski & Kocoshis 1980 |
USA, OH
148 respiratory-allergic children with reproduced symptoms after food challenge |
soy formula 5% | Ogle et al. 1980 |
USA, San Diego, CA
cow's milk-sensitive infants |
soybean 25% | Wilson & Hamburger 1988 |
2 Outgrowing of Soybean Allergy
Country / Subjects | Loss of Sensitivity to | References |
USA
Food allergic patients |
soy, egg, milk, wheat, and peanut:
26% loss (after 1 year of onset, DBPCFC) |
Sampson & Scanlon 1989 |
USA
infants (mean age 8 weeks) with food protein-induced enterocolitis syndrome caused by soybean |
soy in 2 of 8 (after 25 months) | Sicherer et al. 1998 |
Symptoms & Case Reports | References |
systemic reactions
anaphylaxis (5, 7, 12, 13, 15) cutaneous symptoms
gastrointestinal symptoms
respiratory symptoms
other symptoms
|
(1) Virchow 1965
(2) Fries 1971 (3) Bush & Cohen 1977 (4) Whitington & Gibson 1977 (5) Moroz & Yang 1980 (6) Bush et al. 1985 (7) Stricker et al. 1986 (8) Richards et al. 1988 (9) Bush et al. 1988 (10) Burks et al. 1991 (11) Gonzalez et al. 1991 (12) Yunginger et al. 1991 (13) Patane et al. 1992 (14) Herian et al. 1990 (15) Andersen & Nissen 1993 (16) Burks et al. 1994 (17) Lavaud et al. 1994 (18) Machida et al. 1994 (19) Räsänen et al. 1994 (20) Magnolfi et al. 1996 (21) Sicherer et al. 1998 (22) Niggemann et al. 1999 |
Percentage of reactions
cutaneous 68%, gastrointestinal 77%, respiratory 23% in 31 soybean-allergic patients with atopic dermatitis (1) cutaneous 58%, gastrointestinal 14%, both 28%, respiratory 0%, early reaction 57%, late reactions 43% in 7 soybean-allergic patients (2) |
(1) Sampson & Ho 1997
(2) Niggemann et al. 1999 |
4 Diagnostic Features of Soybean Allergy
Parameters / Subjects | Outcome | References |
IgA and IgM
5 patients with soy allergy (previously suffering from cow's milk allergy) |
increased numbers of IgA- and IgM- containing cells (jejunal biopsy) | Perkkio et al. 1981 |
IgE and IgD
13 children with various intestinal diseases |
increased levels of IgE and IgD antibodies specific for soybean agglutinin (and milk proteins) in basal and pancreozymin- stimulated duodenal fluid | Freier et al. 1983 |
T-Cells
7 cases of fatal soybean dust-induced asthma |
reduced numbers of CD3+ and CD8+ T-cells in airways | Synek et al. 1996 |
Ig-Classes
a) 12 soydust-asthmatic patients b) 23 asthmatic patients c) 32 non-allergic subjects |
positive results in patients (specific Ig):
a) IgE 100%, IgG 75%, IgG1 16.6%, IgG2 8.3%, IgG3 0%, IgG4 66.6%, IgA 25%, and IgM 25% b) IgE 4.3%, others negative c) IgE 0%, IgG 0%, IgG1 6.2%, IgG2 9.4%, IgG3 9.4%, IgG4 9.4%, IgA 6.2%, and IgM 6.2% significant positive correlation: for IgE and IgG4 in a) only |
Codina et al. 1997a |
a) IgE and DBPCFC
b) SPT and DBPCFC food-allergic children with atopic dermatitis |
a) predictive values of specific IgE > 0.35 kU/L
positive preditive value 21% (50% for IgE > 65 kU/L) negative preditive value 95% b) predictive values of SPT ( > 3 mm) positive preditive value 35% negative preditive value 84% |
Sampson & Ho 1997 |
IgE and DBPCFC
children with atopic dermatitis |
a) Specific serum IgE in children with
positive oral provocation: 7.4 kU/L negative oral provocation: 3.2 kU/L (no significant difference) b) predictive value of specific IgE > 0.35 kU/L positive preditive value 23% negative preditive value 100% |
Niggemann et al. 1999 |
Proteins / Glycoproteins | Allergen Nomenclature | References |
Soybean Hydrophobic Protein | Gly m 1.0101, Gly m 1.0102 | Gonzalez et al. 1995 |
Soybean Hull Protein | Gly m 2 | Codina et al. 1997b |
Soybean Profilin | Gly m 3 | Rihs et al. 1999 |
Soybean Vacuolar Protein (Gly m Bd 30K) | (Gly m 1)* | Ogawa et al. 1991 |
Glycinin | Djurtoft et al. 1991 | |
beta-Conglycinin | Ogawa et al. 1995 | |
Kunitz-trypsin Inhibitor | Moroz & Yang 1980 ,
Burks et al. 1994b ,
Baur et al. 1996 |
6.1 Sensitization to Soybean Allergens
Country / Subjects | Sensitivity to | References |
Australia, North Ryde
8 peanut sensitive patients |
soybean lectin: agglutinin (30 kDa) in all patients (RAST) | Barnett & Howden 1987 |
Denmark
10 soybean sensitive patients |
Glycinin in 90%
glycinin subunits in 100% (EAST) |
Djurtoft et al. 1991 |
Germany, Bochum
14 soybean-sensitized asthmatic bakers |
trypsin inhibitor in 86%
lipoxidase in 43% lectin in 21% (RAST) 14 kDa / pI 8 allergen in 14% (2D-immunoblot) |
Baur et al. 1996 |
Germany, Bochum
13 soybean-sensitized patients |
profilin (Gly m 3) in 69% (immunoblot, EAST) | Rihs et al. 1999 |
Germany, Langen
6 soybean-allergic adults |
10 proteins, major allergens: 39 and 50 kDa (SDS-PAGE / immunoblot) | Müller et al. 1998 |
Japan, Gunma
5 soybean sensitive children |
2S > 7S > 11S fraction (RAST, allergenic potency: RAST inhibition) | Shibasaki et al. 1980 |
Japan, Tokushima
soybean-sensitized patients with atopic dermatitis |
16 allergens, (14-97 kDa):
7S fraction: 10 allergens, Gly m Bd 30K in 65% alpha- subunit (beta- conglycinin) in 15%; 2S and whey fraction: 6 allergens (SDS-PAGE immunoblot) |
Ogawa et al. 1991
Ogawa et al. 1995 |
Japan, Tokushima
soybean-sensitized patients with atopic dermatitis |
26 kDa allergen (Gly m Bd 28K) | Tsuji et al. 1997 |
Spain, Barcelona
10 patients with asthma |
soybean hull and dust extracts: minor allergens (21 to 42 kDa), major allergen < 14 kDa glycopeptide, pI < 6 (SDS- and IEF-PAGE immunoblot ) | Rodrigo et al. 1990
Swanson et al. 1991 |
Spain, Cartagena
32 patients with asthma |
shell allergens of soy dust in 90%; major allergen of 8 kDa (RAST, immunoblot) | Gonzalez et al. 1991 |
Spain, Cartagena
20 patients with asthma sensitized to soy |
Gly m 1.0101 / Gly m 1.0102 in 95%
(EAST) |
Gonzalez et al. 1992 |
Spain, Tarragona
13 patients with asthma sensitized to soy |
5-6 kDa allergen in 62%
15.5-17 kDa allergen in 77% (SDS-PAGE / immunoblot) |
Garcia-Ortega et al. 1998 |
UK, London
21 patients with wheat-induced asthma |
21 kDa allergen in 100%
15 kDa allergen in 19% (SDS-PAGE / immunoblot) |
Sandiford et al. 1995 |
USA, Little Rock, AR
8 Children with atopic dermatitis and soy allergy |
7S and 11S protein fractions: increased specific serum IgE and IgG (ELISA) | Burks et al. 1988 |
USA, Little Rock, AR
8 Children with atopic dermatitis and soy allergy |
crude soy extract and 7S fraction: increased specific
IgE;
whey and 11S: no significant difference in IgE-binding (EAST) 7S and 11S fraction detected by all sera (SDS-PAGE / immunoblot) |
Burks et al. 1991 |
USA, Little Rock, AR
5 patients with atopic dermatitis and soy allergy |
trypsin inhibitor in 1 patient (spec. IgE, immunoblot, EAST) | Burks et al. 1994b |
USA, Little Rock, AR
2 soybean-allergic patients, 1 soybean- and peanut- allergic patient |
17, 21, 26, and 45 kDa allergens (SDS-PAGE / immunoblot) | Eigenmann et al. 1996 |
USA, Little Rock, AR
4 patients with atopic dermatitis and soy allergy |
20, 30-35, 50, and 65 kDa allergens (SDS-PAGE / immunoblot) | Helm et al. 1998 |
USA, Madison, WI
1 soybean-asthmatic patient |
14.8, 17, 21, 48, 52, and 54.5 kDa allergens (SDS-PAGE / immunoblot) | Bush et al. 1988 |
USA, Madison, WI
7 soybean allergic adults |
50-60 kDa allergens in 57% (patients with soy and peanut
allergy)
20 kDa allergen in 29% (detected by monosensitized patients) 14 kDa allergen in 14% (SDS-PAGE / immunoblot) |
Herian et al. 1990 |
Extract / Purified Allergens | Methods | References |
Hydrophobic protein (Gly m 1.0101) | 60% ethanolic extract of seeds | Odani et al. 1987 |
Commercial and self-prepared extracts | abscence of high Mr proteins in commercial extracts (SDS-PAGE immunoblot) | Herian et al. 1992 |
Gly m 1.0101, Gly m 1.0102 | Purification by SEC / RP-HPLC | Gonzalez et al. 1992 |
Soybean trypsin inhibitor | Extraction from soy protein isolate with PBS for 4h at 4°C; Purification by gel filtration and electroelution | Burks et al. 1994b |
Gly mBd 28K | Isolation from defatted soybean flakes using 5 chromatographic steps including immunoaffinity chromatography with a mAb | Tsuji et al. 1997 |
Soybean proteins | Soybeans frozen, ground (<-5°C) and extracted
with PBS for 4h at 4°C
Soybean lecithin extracted in a two phase aqueous / organic solvent system, purification of aqueous phase by gelchromatography |
Müller et al. 1998 |
Soybean hull | grounded hulls: extraction with ammonium bicarbonate buffer (0.2 M, pH 7.9) overnight, centrifugation, dialysis and centrifugation | Morell et al. 1999 |
Cross-Reacting Allergens | Subjects / Methods | References |
Soybean
soybean (sensitivity in 90% of patients), peanut (90%), green pea (80%), lima bean (53%), string bean (43%)* |
30 atopic children with suspected soybean allergy (Skin test) | Fries 1971 |
Soybean
peanut, garden pea, and chick pea |
15 peanut-sensitive patients (RAST-inhibition) | Barnett et al. 1987 |
Soybean allergen
(17 kDa)
green pea (17 kDa) |
1 patient with asthma (immunoblotting) | Bush et al. 1988 |
Soybean
soybean (sensitivity in 43% of patients), peanut (87%), green bean (22%), pea (26%), and lima bean (41%)* |
69 legume-sensitive patients (SPT) (1)
frequency of multiple sensitization: 4.9% (DBPCFC, 41 patients) (1) in vitro cross-reactivity did not correlate with clinical hypersensitivity (SDS-PAGE and dot / immunoblot) (2) |
(1) Bernhisel-Broadbent
& Sampson 1989
(2) Bernhisel-Broadbent et al. 1989 |
Soybean
peanut |
patient allergic to peanut and soy:
73% reduction of IgE-binding to peanut after adsorption of cross-reacting antibodies (ELISA) |
Eigenmann et al. 1996 |
Soybean
wheat, rye, and barley flours |
21 patients with wheat-induced asthma
(RAST inhibition) |
Sandiford et al. 1995 |
Soybean
wheat flour (sensitivity in 80% of patients), rye flour 66%, alpha-amylase of Aspergillus oryzae (Asp o 2) 33%* |
14 soybean-sensitized asthmatic bakers
(RAST) |
Baur et al. 1996 |
Soybean
peanuts and peas |
4 peanut allergic and 2 pea allergic adults (RAST-inhibition) | Hagner et al. 1998 |
Unique Allergens | Subjects / Methods | References |
Soybean / Peanut
46 and 21 kDa allergens from soybean did not cross-react with peanut allergens; 46, 29, 25, 19, 17, 14, and 5 kDa allergens from peanut did not cross-react with soybean allergens |
2 patients allergic to peanut and soy
3 patients allergic to peanut a) removal of cross-reacting antibodies from serum by soy- and peanut-affinity chromatography, respectively b) detection of unique IgE-binding proteins in SDS-PAGE immunoblot |
Eigenmann et al. 1996 |
9 Stability of Soybean Allergens
Treatment | Effects | References |
Soybean hull
(a) fresh, (b) stored, (c) stored and heated for 16 h |
IgE- and IgG4-binding:
stored > fresh extracts heated > untreated extracts (EAST inhibition) heated to 80°C: absence of several bands > 20 kDa abscence of 1 major allergen (probably Gly m 2) 2 new IgE-binding bands of 10 and 15.3 kDa 1 new IgG4-binding band of 10 kDa as compared to RT, 37°C, 55°C treatment (SDS-PAGE immunoblot) |
Codina et al. 1998 |
Soybean hull
fresh and glycerinated extracts: storage (30 days, -70°C to 4°C) |
increase of positivities in SPT with all glycerinated
extracts after 30 days of storage,
loss of protein bands > 66 kDa for non-glycerinated extract stored at 4°C (SDS-PAGE) |
Morell et al. 1999 |
Soybeans
microwave 700W, 25 min 15 soybean-allergic adults |
IgE-binding (EAST):
raw soybean: 15 sera heated soybean: 9 sera |
Vieths et al. 1995 |
Soybeans
cooking 100°C, 2h 6 soybean-allergic adults |
IgE-binding (EAST):
raw soybean: 6 sera cooked soybean: 3 sera max. inhibition of Ig-binding to heated soybean extract (EAST): 39% by raw extract 89% by heated extract |
Müller et al. 1998 |
crude soy protein
2 step enzyme digestion a) pepsin and b) trypsin, chymotrypsin and intestinal mucosal peptidase digestion |
50%-inhibition concentration: 10 fold increased for digested soy proteins (EAST inhibition) | Burks et al. 1992 |
crude soy protein
enzyme digestion (2 proteases) |
reduced IgE-binding (immunoblot) | Yamanishi et al. 1996 |
crude soy protein
heat 80°C and 120°C, 60 min |
decrease in IgE-binding
80°C: no change in IgG-binding 120°C: decrease in IgG-binding (ELISA) |
Burks et al. 1991 |
crude soy, 7S-, 11S-, and
whey proteins
heat RT to 100°C, 5 to 60 min |
no significant changes in IgE- and IgG-binding (EAST inhibition) | Burks et al. 1992 |
soy whey proteins
heat 80°C and 120°C, 60 min |
80°C: no change in IgE- and IgG-binding
120°C: decrease in IgE- and IgG-binding (ELISA) |
Burks et al. 1991 |
11S-, 7S- and 2S-globulins
heat 80°C, 100°C and 120°C, 30 min |
80°C: 2S-globuline slightly increased,
11S and 7S reduced IgE-binding (42-75%) 100°C, 120°: decreased IgE-binding for all fractions (39-83%) (RAST) |
Shibasaki et al. 1980 |
11S- and 7S-globulins
heat 80°C and 120°C, 60 min |
80°C: decrease in IgE-binding; decrease (7S) and
increase (11S) in IgG-binding
120°C: decrease in IgE- and IgG-binding (ELISA) |
Burks et al. 1991 |
Reported Adverse Reactions | References |
Food / Food additives
Fatal anaphylaxis after ingestion of sausage pizza fortified with soy protein (1) Symptoms after ingestion of tofu, soybean salat, soybean sprouts, and spring rolls (2) Baker's asthma induced by soy lecithin (Skin test, RAST, bronchial challenge) (3) Soy proteins in Spanish sausage products (chorizo, salchichon, mortadella, and boiled ham), doughnut and soup stock cubes (Skin test, RAST, bronchial and oral challenge) (4) Anaphylactic symptoms caused by pizza containing soy proteins (5) |
(1) Yunginger et al. 1991
(2) Mistereck et al. 1992 (3) Lavaud et al. 1994 (4) Vidal et al. 1997 (5) Senne et al. 1998 |
Pharmaceuticals
Urticarial eruptions associated with lipid emulsions (1) Anaphylactic shock after infusion of soybean oil based preparation for parenteral nutrition (2) Systemic reactions (flush, dyspnea, tachycardia, hypotension, back pain) to a parenteral lipid emulsion, reexposure to parenteral solutions containing no soy lecithin emulsifier was tolerated (3) |
(1) Buchman & Ament 1991
(2) Andersen & Nissen 1993 (3) Weidmann et al. 1997 |
Allergens in Soybean Products | Content / Products | References |
Soybean Proteins
7 soybean-allergic adults (RAST inhibition) |
Inhibitory potency of IgE-binding to raw soybean proteins:
sprouts > acid- hydrolyzed sauce , tofu, hydrolyzed vegetable protein, temeph, miso > mold-hydrolyzed sauce |
Herian et al. 1993 |
Soybean Proteins
15 soybean-allergic adults (EAST inhibition) |
IgE-binding proteins in
soy-milk, tofu, textured soy-protein |
Vieths et al. 1995 |
Soybean Proteins
Patients with atopic dermatitis and high levels of IgE; Determination of IgG-binding to protein fractions (ELISA, immunoblot) |
IgG-binding proteins in
commercial margarines not detected in hypoallergenic magarine |
Yokota et al. 1996 |
Soybean Proteins
30 soybean-allergic adults (immunoblot) |
IgE-binding proteins in
lecithins (31 kDa allergen) protein contents: soybean lecithin 2.8 µg / 100 g soybean oil 1.4 to 4.0 µg / 100 g |
Awazuhara et al. 1998 |
Soybean Proteins
6 soybean-allergic adults (EAST, immunoblot) |
IgE-binding proteins in
4/6 commercial lecithins: 27, 39, and 40 kDa allergens |
Müller et al. 1998 |
Gly m Bd 30K
Determination of Gly m Bd 30K (ELISA) |
high concentrations in
soy milk, tofu, kori-dofu, yuba, and in soybean protein isolate containing foods meat balls, beef croquettes, and fried chicken low concentration in kinako not detected in fermented foods (miso, shoyu, and natto) |
(1) Tsuji et al. 1995 |
Reported Safe Products | References |
Food
6 commercial soybean oil samples: safe ingestion by soybean-allergic individuals (1) |
(1) Bush et al. 1985 |
Pharmaceuticals
tolerance to parenteral solutions containing no soy lecithin emulsifier (1) |
(1) Weidmann et al. 1997 |
Allergen Depleted Products | Method | References |
Soy milk
90% removal of allergen Gly m Bd 30K (1) |
salted out with Na2SO4, acidifying to pH 4.5 and centrifugation (1) | (1) Samoto et al. 1994 |
Soy milk
from a genetically mutated soybean (Tohoku 124): 99.78% removal of allergen Gly m Bd 30K (1) |
salted out with Na2SO4, acidifying to pH 4.5 and centrifugation (1) | (1) Samoto et al. 1996b |
11 Soybean Protein in Infant Feed
Subjects | Feeding / Formula | References |
328 children with a positive family history of allergy (15 years follow up) | Breast fed infants were found to have approximately one-half the incidence of atopy of cow's milk or soy based formula fed infants | Gruskay 1982 |
16 infants with congenital lactase deficiency (lactose malabsorption) | 10 on soy-based formula
1 had allergic symptoms |
Savilahti et al. 1983 |
101 newborn infants of atopic parents
(total serum IgE) |
development of atopic disease
breast-fed group: 38% with IgE > 0.8 U/ml 12% with IgE < 0.8 U/ml soy-fed group: 33% with IgE > 0.8 U/ml 16% with IgE < 0.8 U/ml cow's milk-fed group: 90% with IgE > 0.8 U/ml 17% with IgE < 0.8 U/ml |
Businco et al. 1983 |
97 brest fed and 124 non brest fed infants | development of atopic eczema
breast-fed group: 22% (restricted maternal diet) 48% (no restricted maternal diet) soy-fed group: in 63% cow's milk-fed group: in 70% casein hydrolysate-fed group: in 21% |
Chandra et al. 1989a |
72 infants with family history of atopy (each group) | incidence of atopic eczema, wheezing, rhinitis, gastrointestinal
symptoms, or colic
breast-fed group: in 20% soy-fed group: in 37% cow's milk-fed group: in 36% cow's milk whey hydrolysate-fed group: in 7% cumulative incidence of atopic disease: breast-fed and whey hydrolysate-fed group < cow's milk and soy-formula fed group |
Chandra et al. 1989b
Chandra & Hamed 1991 Chandra 1997 |
20 cow's milk allergic infants | incidence of allergic symptoms:
2S protein fraction depleted soy milk in 17% of infants |
Marano et al. 1989 |
(a) 12 infants with protracted enteritis
(b) 10 infants with atopic eczema |
fed with lactose-free soy and beef hydrolysate based
formula:
improvement of symptoms in both groups, allergic symptoms in 1 (a) and 3 (b) infants who were previously fed with intact soy protein |
Donzelli et al. 1990 |
21 infants with gastrointestinal symptoms of cow's milk and/or soy protein intolerance | fed with whey protein hydrolysate formula: improvement of symptoms | Merrit et al. 1990 |
40 atopic children | specific IgE against soy / beef collagen hydrolysate in 1 patient | Gortler & Urbanek 1990 |
43 patients with possible milk- and/or soy-protein enterocolitis | cow's milk
23% positive challenge 2 hydrolyzed soy protein isolates a) 33% positive challenge b) 30% positive challenge |
Burks et al. 1994 |
12 infants with adverse reactions to soy formula, whey hydrolysate, or casein hydrolysate (4) | infant formula composed of individual amino acids: no symptoms | Hill et al. 1995 |
analysis of 17 studies | allergy to soy-based formula:
in 27% of patients (total incidences), 3% (DBPCFC) and 4% (positive challenge) |
Cantani & Lucenti 1997 |
12 Allergenicity of Genetically Modified
Soybeans
Product | References |
Transgenic Soybean / Pesticide resistant
Aim: glyphosate-tolerant soybeans (product Roundup Ready) Modification: Introduced enzyme: 5-enolpyruvylshikimate- 3-phosphate synthase enzyme derived from Agrobacterium sp. strain Digestability: introduced enzyme degrades readily in simulated gastric and intestinal fluids Allergenicity: no data |
Harrison et al. 1996 |
Transgenic Soybean / Brazil nut protein
Aim: Improvement of nutritional quality Modification: Introduced allergen: methionine-rich 2S albumin from the Brazil nut (Betholletia excelsa) Allergenicity: All patients with positive reactions to brazil nut proteins were positive to the transgenic soybean (SPT, RAST, immunoblot) |
Nordlee et al. 1996 |
Transgenic Soybean / Corn proteins
Aim: Improvement of nutritional quality (amino acid composition) Modification: Introduced corn proteins: 10 kDa and HSZ Allergenicity: Both proteins did not bind IgE from sera of corn-reactive subjects (immunoblot) |
Lehrer & Reese 1997 |
Transgenic Soybean / Oleic acid
Modification: transgenic soybean with an altered fatty acid profile Allergenicity: no difference in allergen content of wild-type and transgenic soybean extracts (RAST inhibition, immunoblot) |
Lehrer & Reese 1997 |
Cultivar Tohoku 124
lacks alpha- and alpha'-subunits of conglycinin which bind allergen Gly m Bd 30K (1) and lacks Gly m Bd 28K (2) |
(1) Samoto et al. 1996b
(2) Samoto et al. 1998 |
Transgenic Soybean
lacking the 7S globulin (beta-conglycinin) subunits, alpha, alpha' and beta (1) |
(1) Hayashi et al. 1998 |